Hospital Mater Dei (BSP:MATD3) Marketable Securities: R$27 Mil (As of Mar. 2026)


BSP:MATD3 Hospital Mater Dei SA BSP:MATD3
85 GF Score
Price R$4.69
GF Value R$5.87
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Hospital Mater Dei Marketable Securities?

Hospital Mater Dei BSP:MATD3 -0.64% 85 Marketable Securities is R$27 Mil as of Mar. 2026. GuruFocus rates BSP:MATD3 with a GF Score™ of 85/100 and a GF Value™ of R$5.87 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Hospital Mater Dei's Marketable Securities for the quarter that ended in Mar. 2026 was R$27 Mil.

Hospital Mater Dei's annual Marketable Securities declined from Dec. 2023 (R$92 Mil) to Dec. 2024 (R$53 Mil) and declined from Dec. 2024 (R$53 Mil) to Dec. 2025 (R$26 Mil).

Hospital Mater Dei  (BSP:MATD3) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Hospital Mater Dei Marketable Securities Related Terms

Hospital Mater Dei Marketable Securities Historical Data

* Premium members only.

The historical data trend for Hospital Mater Dei's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hospital Mater Dei Marketable Securities Chart

Hospital Mater Dei Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only 278.37 131.88 91.83 52.74 26.33

Hospital Mater Dei Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.30 24.68 25.52 26.33 27.17
BSP:MATD3
85GF Score
Hospital Mater Dei SA BSP:MATD3
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hospital Mater Dei Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of R$27 Mil mean?
Hospital Mater Dei (BSP:MATD3) has a Marketable Securities of R$27 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Hospital Mater Dei and its competitors.
Is Hospital Mater Dei's Marketable Securities too high?
Hospital Mater Dei's current Marketable Securities is R$27 Mil. Overall, Hospital Mater Dei has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's Marketable Securities compare to HCA and THC?
Hospital Mater Dei's Marketable Securities of R$27 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Hospital Mater Dei and its competitors. Hospital Mater Dei's current Marketable Securities is R$27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$5.87, compared to a current price of R$4.69 — trading 20.1% below its estimated fair value. The current Marketable Securities is R$27 Mil. Hospital Mater Dei's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current Marketable Securities is R$27 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?

Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued. The current stock price of R$4.69 is trading 20.1% below its estimated GF Value™ of R$5.87. GuruFocus considers Hospital Mater Dei to be Modestly Undervalued.

Key valuation signals for BSP:MATD3:

  • Marketable Securities: R$27 Mil
  • GF Value™: R$5.87 vs. price of R$4.69 (20.1% below fair value)
  • GF Score™: 85/100 with 3 warning signs

No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hospital Mater Dei Business Description

Address Rua Mato Grosso, No. 1, 100, Bairro Santo Agostinho, Belo Horizonte, MG, BRA, 30.190-081
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
85GF Score

Get the complete analysis for BSP:MATD3

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$4.69
Price
R$5.87
GF Value